🟢 Conexeu Sciences is trading 10.37% up today amid broader biotech-sector strength

Conexeu Sciences is trading at $3.81, up 10.37%, with biotech-sector strength the most plausible context, not a confirmed direct cause.

• No company-specific announcement was identified for October 9; the latest release, on October 6, concerned progress toward a planned FDA 510(k) submission.
• The supplied market context reports XBI up 2.50%, alongside IPO activity and M&A optimism; TRex Bio’s IPO was priced October 9. Broader indexes are up less than 0.5%.